vs

Side-by-side financial comparison of AGENUS INC (AGEN) and AMTECH SYSTEMS INC (ASYS). Click either name above to swap in a different company.

AGENUS INC is the larger business by last-quarter revenue ($34.2M vs $19.0M, roughly 1.8× AMTECH SYSTEMS INC). AMTECH SYSTEMS INC runs the higher net margin — 0.6% vs -31.0%, a 31.6% gap on every dollar of revenue. On growth, AGENUS INC posted the faster year-over-year revenue change (27.5% vs -22.2%). Over the past eight quarters, AGENUS INC's revenue compounded faster (10.5% CAGR vs -13.6%).

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.

Amtech Systems Inc is a global manufacturer of advanced thermal processing and automation equipment primarily serving the semiconductor, solar photovoltaic, and LED production sectors. Its product portfolio includes soldering, diffusion, and deposition systems, with key markets spanning North America, East Asia, and Western Europe, catering to leading electronic component and clean energy manufacturing clients.

AGEN vs ASYS — Head-to-Head

Bigger by revenue
AGEN
AGEN
1.8× larger
AGEN
$34.2M
$19.0M
ASYS
Growing faster (revenue YoY)
AGEN
AGEN
+49.6% gap
AGEN
27.5%
-22.2%
ASYS
Higher net margin
ASYS
ASYS
31.6% more per $
ASYS
0.6%
-31.0%
AGEN
Faster 2-yr revenue CAGR
AGEN
AGEN
Annualised
AGEN
10.5%
-13.6%
ASYS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AGEN
AGEN
ASYS
ASYS
Revenue
$34.2M
$19.0M
Net Profit
$-10.6M
$108.0K
Gross Margin
44.8%
Operating Margin
42.1%
4.1%
Net Margin
-31.0%
0.6%
Revenue YoY
27.5%
-22.2%
Net Profit YoY
77.3%
-65.4%
EPS (diluted)
$0.09
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AGEN
AGEN
ASYS
ASYS
Q4 25
$34.2M
$19.0M
Q3 25
$30.2M
$19.8M
Q2 25
$25.7M
$19.6M
Q1 25
$24.1M
$15.6M
Q4 24
$26.8M
$24.4M
Q3 24
$25.1M
$24.1M
Q2 24
$23.5M
$26.7M
Q1 24
$28.0M
$25.4M
Net Profit
AGEN
AGEN
ASYS
ASYS
Q4 25
$-10.6M
$108.0K
Q3 25
$63.9M
$1.1M
Q2 25
$-30.0M
$106.0K
Q1 25
$-26.4M
$-31.8M
Q4 24
$-46.8M
$312.0K
Q3 24
$-67.2M
$-536.0K
Q2 24
$-54.8M
$438.0K
Q1 24
$-63.5M
$970.0K
Gross Margin
AGEN
AGEN
ASYS
ASYS
Q4 25
44.8%
Q3 25
97.9%
44.4%
Q2 25
99.1%
46.7%
Q1 25
99.4%
-2.1%
Q4 24
99.6%
38.4%
Q3 24
99.4%
40.7%
Q2 24
99.5%
36.5%
Q1 24
99.6%
33.2%
Operating Margin
AGEN
AGEN
ASYS
ASYS
Q4 25
42.1%
4.1%
Q3 25
-15.0%
9.3%
Q2 25
-65.0%
4.7%
Q1 25
-55.3%
-202.7%
Q4 24
-96.5%
1.4%
Q3 24
-125.5%
0.1%
Q2 24
-128.4%
3.1%
Q1 24
-117.4%
5.4%
Net Margin
AGEN
AGEN
ASYS
ASYS
Q4 25
-31.0%
0.6%
Q3 25
211.4%
5.4%
Q2 25
-116.8%
0.5%
Q1 25
-109.6%
-204.2%
Q4 24
-174.4%
1.3%
Q3 24
-267.7%
-2.2%
Q2 24
-233.1%
1.6%
Q1 24
-226.6%
3.8%
EPS (diluted)
AGEN
AGEN
ASYS
ASYS
Q4 25
$0.09
$0.01
Q3 25
$1.94
$0.08
Q2 25
$-1.00
$0.01
Q1 25
$-1.03
$-2.23
Q4 24
$-1.95
$0.02
Q3 24
$-3.08
$-0.04
Q2 24
$-2.52
$0.03
Q1 24
$-3.04
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AGEN
AGEN
ASYS
ASYS
Cash + ST InvestmentsLiquidity on hand
$3.0M
$22.1M
Total DebtLower is stronger
$44.7M
$162.0K
Stockholders' EquityBook value
$-271.1M
$54.1M
Total Assets
$226.8M
$94.1M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AGEN
AGEN
ASYS
ASYS
Q4 25
$3.0M
$22.1M
Q3 25
$3.5M
$17.9M
Q2 25
$9.5M
$15.6M
Q1 25
$18.5M
$13.4M
Q4 24
$40.4M
$13.2M
Q3 24
$44.8M
$11.1M
Q2 24
$93.7M
$13.2M
Q1 24
$52.9M
$13.0M
Total Debt
AGEN
AGEN
ASYS
ASYS
Q4 25
$44.7M
$162.0K
Q3 25
$34.2M
$168.0K
Q2 25
$33.9M
$127.0K
Q1 25
$33.6M
$135.0K
Q4 24
$33.2M
$161.0K
Q3 24
$189.0K
Q2 24
$177.0K
Q1 24
$65.0K
Stockholders' Equity
AGEN
AGEN
ASYS
ASYS
Q4 25
$-271.1M
$54.1M
Q3 25
$-274.1M
$53.4M
Q2 25
$-354.6M
$51.7M
Q1 25
$-341.8M
$51.0M
Q4 24
$-326.4M
$82.4M
Q3 24
$-292.3M
$82.4M
Q2 24
$-241.3M
$81.7M
Q1 24
$-201.4M
$80.9M
Total Assets
AGEN
AGEN
ASYS
ASYS
Q4 25
$226.8M
$94.1M
Q3 25
$233.9M
$92.9M
Q2 25
$185.2M
$89.5M
Q1 25
$200.2M
$83.4M
Q4 24
$226.3M
$117.8M
Q3 24
$238.5M
$119.3M
Q2 24
$292.4M
$127.1M
Q1 24
$256.6M
$116.5M
Debt / Equity
AGEN
AGEN
ASYS
ASYS
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AGEN
AGEN
ASYS
ASYS
Operating Cash FlowLast quarter
$-16.6M
$4.1M
Free Cash FlowOCF − Capex
$3.8M
FCF MarginFCF / Revenue
20.2%
Capex IntensityCapex / Revenue
0.0%
1.5%
Cash ConversionOCF / Net Profit
37.99×
TTM Free Cash FlowTrailing 4 quarters
$8.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AGEN
AGEN
ASYS
ASYS
Q4 25
$-16.6M
$4.1M
Q3 25
$-14.7M
$2.3M
Q2 25
$-20.2M
$2.5M
Q1 25
$-25.6M
$210.0K
Q4 24
$-28.7M
$2.9M
Q3 24
$-53.3M
$879.0K
Q2 24
$-38.2M
$3.7M
Q1 24
$-38.2M
$336.0K
Free Cash Flow
AGEN
AGEN
ASYS
ASYS
Q4 25
$3.8M
Q3 25
$2.0M
Q2 25
$-20.2M
$2.0M
Q1 25
$-25.6M
$201.0K
Q4 24
$-28.7M
$2.7M
Q3 24
$-53.3M
$447.0K
Q2 24
$-38.6M
$322.0K
Q1 24
$-38.2M
$-884.0K
FCF Margin
AGEN
AGEN
ASYS
ASYS
Q4 25
20.2%
Q3 25
10.2%
Q2 25
-78.7%
10.1%
Q1 25
-106.5%
1.3%
Q4 24
-107.0%
11.2%
Q3 24
-212.2%
1.9%
Q2 24
-164.4%
1.2%
Q1 24
-136.5%
-3.5%
Capex Intensity
AGEN
AGEN
ASYS
ASYS
Q4 25
0.0%
1.5%
Q3 25
0.0%
1.2%
Q2 25
0.0%
2.8%
Q1 25
0.0%
0.1%
Q4 24
0.3%
0.6%
Q3 24
0.0%
1.8%
Q2 24
2.0%
12.5%
Q1 24
0.1%
4.8%
Cash Conversion
AGEN
AGEN
ASYS
ASYS
Q4 25
37.99×
Q3 25
-0.23×
2.12×
Q2 25
23.89×
Q1 25
Q4 24
9.19×
Q3 24
Q2 24
8.35×
Q1 24
0.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AGEN
AGEN

Non Cash Royalty Revenue$31.1M91%
Other$3.2M9%

ASYS
ASYS

Thermal Processing Solutions$14.0M74%
Semiconductor Fabrication Solutions$5.0M26%

Related Comparisons